Company Analysis Tenet Healthcare Corporation
1. Summary
Advantages
- The stock's return over the last year (43.5%) is higher than the sector average (-31.87%).
- Current debt level 53.71% is below 100% and has decreased over 5 years from 63.17%.
- The company's current efficiency (ROE=38%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (126.19 $) is higher than fair price (89.81 $)
- Dividends (0%) are below the sector average (1.32%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Tenet Healthcare Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -9.7% | -2.2% | -1.4% |
| 90 days | -22.4% | -33.2% | 0.8% |
| 1 year | 43.5% | -31.9% | 21.5% |
THC vs Sector: Tenet Healthcare Corporation has outperformed the "Healthcare" sector by 75.36% over the past year.
THC vs Market: Tenet Healthcare Corporation has outperformed the market by 22.01% over the past year.
Stable price: THC is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: THC with weekly volatility of 0.8365% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (126.19 $) is higher than the fair price (89.81 $).
Price is higher than fair: The current price (126.19 $) is 28.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (12.99) is lower than that of the sector as a whole (114.5).
P/E vs Market: The company's P/E (12.99) is lower than that of the market as a whole (70.26).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.44) is lower than that of the sector as a whole (9.44).
P/BV vs Market: The company's P/BV (1.44) is lower than that of the market as a whole (22.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.3863) is lower than that of the sector as a whole (4.13).
P/S vs Market: The company's P/S indicator (0.3863) is lower than that of the market as a whole (15.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.95) is lower than that of the sector as a whole (17.79).
EV/Ebitda vs Market: The company's EV/Ebitda (6.95) is lower than that of the market as a whole (24.37).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -4.09% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-4.09%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-57.12%).
5.4. ROE
ROE vs Sector: The company's ROE (38%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (38%) is higher than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (2.16%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (2.16%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (10.59%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (10.59%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.32%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (56%) are at a comfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 31.10.2024 | Foo Lisa Y EVP, Commercial Ops |
Sale | 155.94 | 623 760 | 4 000 |
| 05.09.2024 | Ramsey R. Scott Principal Accounting Officer |
Sale | 162.06 | 1 879 730 | 11 599 |
| 16.08.2024 | Arbour Paola M EVP, Chief Information Officer |
Sale | 156 | 1 306 810 | 8 377 |
| 15.08.2024 | Sutaria Saumya Chairman & CEO |
Sale | 154.6 | 2 129 310 | 13 773 |
| 15.08.2024 | Sutaria Saumya Member of immediate family of |
Purchase | 154.59 | 2 129 170 | 13 773 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
